Stratos Genomics Inc., a Seattle, WA-based developer of a single-molecule detection process, received an $829k over-two-year grant from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).
The company will use the funds to further develop its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics.
Established in 2007 as a spin-off of Seattle-based Stratos Group LLC., Stratos Genomics aims to establish its “Sequencing by Expansion™” (SBX™) method, a single-molecule detection process designed to allow accurate, ultra-low-cost whole genome sequencing.
The venture-backed company (see related news) is led by CEO Allan Stephan, CSO Mark Kokoris (principal investigator for the grant) and CTO Bob McRuer, Ph.D.
08/06/2011: Stratos Genomics Raises Additional $2.1M in Series A Funding
08/09/2010: Stratos Genomics Closes $4M Series A Financing